相似文献
1
Cardioprotective activity of a novel and potent competitive inhibitor of lactate dehydrogenase.
FEBS Lett. 2010 Jan 4;584(1):159-65. doi: 10.1016/j.febslet.2009.11.022.
2
The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.
Basic Res Cardiol. 2012 May;107(3):263. doi: 10.1007/s00395-012-0263-7. Epub 2012 Mar 31.
3
Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties.
J Pharmacol Exp Ther. 2006 Jun;317(3):921-8. doi: 10.1124/jpet.105.100834. Epub 2006 Feb 8.
4
PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H719-27. doi: 10.1152/ajpheart.00394.2008. Epub 2009 Jan 16.
5
Sevoflurane post-conditioning protects isolated rat hearts against ischemia-reperfusion injury via activation of the ERK1/2 pathway.
Acta Pharmacol Sin. 2014 Dec;35(12):1504-13. doi: 10.1038/aps.2014.78. Epub 2014 Oct 27.
6
Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.
Am J Physiol Regul Integr Comp Physiol. 2009 Dec;297(6):R1681-90. doi: 10.1152/ajpregu.90746.2008. Epub 2009 Oct 7.
7
KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Arch Pharm Res. 2008 Apr;31(4):482-9. doi: 10.1007/s12272-001-1182-9. Epub 2008 May 1.
8
Triptolide Attenuates Myocardial Ischemia/Reperfusion Injuries in Rats by Inducing the Activation of Nrf2/HO-1 Defense Pathway.
Cardiovasc Toxicol. 2016 Oct;16(4):325-35. doi: 10.1007/s12012-015-9342-y.
9
Cardioprotection by sulfaphenazole, a cytochrome p450 inhibitor: mitigation of ischemia-reperfusion injury by scavenging of reactive oxygen species.
J Pharmacol Exp Ther. 2007 Dec;323(3):813-21. doi: 10.1124/jpet.107.129486. Epub 2007 Sep 14.
10
Effects of KR-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarction and arrhythmias induced by ischemia and reperfusion.
Eur J Pharmacol. 2005 Oct 31;523(1-3):101-8. doi: 10.1016/j.ejphar.2005.08.054. Epub 2005 Oct 14.
引用本文的文献
1
Peptides inhibiting the assembly of monomeric human l-lactate dehydrogenase into catalytically active homotetramer decrease the synthesis of lactate in cultured cells.
Protein Sci. 2024 Oct;33(10):e5161. doi: 10.1002/pro.5161.
2
Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases.
Front Pharmacol. 2023 Oct 17;14:1275000. doi: 10.3389/fphar.2023.1275000. eCollection 2023.
3
Effect and Mechanism of Spores on Alleviation of Diabetic Cardiomyopathy in a Pilot in vivo Study.
Diabetes Metab Syndr Obes. 2020 Dec 7;13:4809-4822. doi: 10.2147/DMSO.S281527. eCollection 2020.
4
Regioselective Alkylation of Pyridinium Riboses.
European J Org Chem. 2020 Jan 31;2020(4):446-449. doi: 10.1002/ejoc.201901603. Epub 2019 Dec 4.
5
Small-molecule inhibitors of human LDH5.
Future Med Chem. 2013 Oct;5(16):1967-91. doi: 10.4155/fmc.13.151.
6
Escherichia coli transcription termination factor NusA: heat-induced oligomerization and chaperone activity.
Sci Rep. 2013;3:2347. doi: 10.1038/srep02347.
7
Transcription elongation factor GreA has functional chaperone activity.
PLoS One. 2012;7(12):e47521. doi: 10.1371/journal.pone.0047521. Epub 2012 Dec 12.
8
Anticancer agents that counteract tumor glycolysis.
ChemMedChem. 2012 Aug;7(8):1318-50. doi: 10.1002/cmdc.201200176. Epub 2012 Jun 8.
本文引用的文献
1
Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.
Physiol Rev. 2008 Apr;88(2):581-609. doi: 10.1152/physrev.00024.2007.
2
Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia.
Am J Physiol Heart Circ Physiol. 2007 Nov;293(5):H3150-8. doi: 10.1152/ajpheart.00587.2006. Epub 2007 Aug 31.
3
A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury.
Cardiovasc Res. 2007 Oct 1;76(1):41-50. doi: 10.1016/j.cardiores.2007.05.029. Epub 2007 Jun 8.
4
Biochemical basis of ischemic heart injury and of cardioprotective interventions.
Curr Med Chem. 2007;14(15):1619-37. doi: 10.2174/092986707780831014.
5
Postconditioning: reduction of reperfusion-induced injury.
Cardiovasc Res. 2006 May 1;70(2):200-11. doi: 10.1016/j.cardiores.2006.01.024. Epub 2006 Mar 20.
6
A novel strong competitive inhibitor of complex I.
FEBS Lett. 2005 Aug 29;579(21):4861-6. doi: 10.1016/j.febslet.2005.07.076.
7
Oxygen, oxidative stress, hypoxia, and heart failure.
J Clin Invest. 2005 Mar;115(3):500-8. doi: 10.1172/JCI24408.
8
Biochemistry of exercise-induced metabolic acidosis.
Am J Physiol Regul Integr Comp Physiol. 2004 Sep;287(3):R502-16. doi: 10.1152/ajpregu.00114.2004.
9
Acidosis-induced apoptosis in human and porcine heart.
Ann Thorac Surg. 2004 Apr;77(4):1376-83. doi: 10.1016/j.athoracsur.2003.07.047.
10
THE COMPARATIVE ENZYMOLOGY OF LACTIC DEHYDROGENASES. I. PROPERTIES OF THE CRYSTALLINE BEEF AND CHICKEN ENZYMES.
J Biol Chem. 1964 Jun;239:1753-61.
Zotero 插件